Question 1

What is Lakefront Biotherapeutics?

Accepted Answer

Lakefront Biotherapeutics is a Entity.

Question 2

How often does Lakefront Biotherapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Lakefront Biotherapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 20, 2026.

Question 4

When was Lakefront Biotherapeutics last mentioned in news?

Accepted Answer

Last active on Jul 06, 2026.

Question 5

What is Lakefront Biotherapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 5 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Lakefront Biotherapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Lakefront Biotherapeutics?

Accepted Answer

Madison Avenue Partners acquires Lakefront shares (Jun 29, 2026, 6 articles).

Question 8

How did the "Madison Avenue Partners acquires Lakefront shares" event impact Lakefront Biotherapeutics?

Accepted Answer

Lakefront Biotherapeutics received a transparency notification that Madison Avenue Partners, LP, along with its affiliates, acquired voting rights, crossing the 5% ownership threshold. This indicates increased investor interest in the company.

Question 9

How did the "AbCellera Appoints Lynn Seely to Board" event impact Lakefront Biotherapeutics?

Accepted Answer

Dr. Lynn Seely was previously a member of the Board of Managers for Lakefront Biotherapeutics LLC.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.